@article{2a7d9a5ce5754e97828eff5b1ef43026,
title = "Improved diagnosis of Parkinson's disease from a detailed olfactory phenotype",
abstract = "Objective: To assess the predictive potential of the complete response pattern from the University of Pennsylvania Smell Identification Test for the diagnosis of Parkinson's disease. Methods: We analyzed a large dataset from the Arizona Study of Aging and Neurodegenerative Disorders, a longitudinal clinicopathological study of health and disease in elderly volunteers. Using the complete pattern of responses to all 40 items in each subject's test, we built predictive models of neurodegenerative disease, and we validated these models out of sample by comparing model predictions against postmortem pathological diagnosis. Results: Consistent with anatomical considerations, we found that the specific test response pattern had additional predictive power compared with a conventional measure – total test score – in Parkinson's disease, but not Alzheimer's disease. We also identified specific test questions that carry the greatest predictive power for disease diagnosis. Interpretation: Olfactory ability has typically been assessed with either self-report or total score on a multiple choice test. We showed that a more accurate clinical diagnosis can be made using the pattern of responses to all the test questions, and validated this against the “gold standard” of pathological diagnosis. Information in the response pattern also suggests specific modifications to the standard test that may optimize predictive power under the typical clinical constraint of limited time. We recommend that future studies retain the individual item responses for each subject, and not just the total score, both to enable more accurate diagnosis and to enable additional future insights.",
author = "Gerkin, {Richard C.} and Adler, {Charles H.} and Hentz, {Joseph G.} and Shill, {Holly A.} and Erika Driver-Dunckley and Mehta, {Shyamal H.} and Sabbagh, {Marwan N.} and Caviness, {John N.} and Dugger, {Brittany N.} and Geidy Serrano and Christine Belden and Smith, {Brian H.} and Lucia Sue and Davis, {Kathryn J.} and Edward Zamrini and Beach, {Thomas G.}",
note = "Funding Information: The Arizona Study for Aging and Neurodegenerative Disorders is supported by the National Institute of Neurological Disorders and Stroke (U24 NS072026 National Brain and Tissue Resource for Parkinson{\textquoteright}s Disease and Related Disorders), the National Institute on Aging (P30 AG19610 Arizona Alzheimer{\textquoteright}s Disease Core Center), the Arizona Department of Health Services (contract 211002, Arizona Alzheimer{\textquoteright}s Research Center), the Arizona Biomedical Research Commission (contracts 4001, 0011, 05-901, and 1001 to the Arizona Parkinson{\textquoteright}s Disease Consortium), the Michael J. Fox Foundation for Parkinson{\textquoteright}s Research, the Mayo Clinic Foundation, and the Sun Health Foundation. We also thank the Arizona Alzheimer{\textquoteright}s Consortium, the National Institute on Aging (AG002132 Core C), the CurePSP Foundation, the Alzheimer{\textquoteright}s Association, the Henry M. Jackson Foundation (HU0001-15-2-0020), Daiichi San-kyo Co., Ltd., the National Institute of Mental Health (R01MH106674), and the National Institute of Biomedical Imaging and Bioengineering (R01EB021711) for funding, the Banner Brain and Body Donation Program for making the data available, and the many individuals who contributed their brains to make this study possible. Funding Information: The Arizona Study for Aging and Neurodegenerative Disorders is supported by the National Institute of Neurological Disorders and Stroke (U24 NS072026, National Brain and Tissue Resource for Parkinson{\textquoteright}s Disease and Related Disorders), the National Institute on Aging (P30 AG19610, Arizona Alzheimer{\textquoteright}s Disease Core Center), the Arizona Department of Health Services (contract 211002, Arizona Alzheimer{\textquoteright}s Research Center), the Arizona Biomedical Research Commission (contracts 4001, 0011, 05-901, and 1001 to the Arizona Parkinson{\textquoteright}s Disease Consortium), the Michael J. Fox Foundation for Parkinson{\textquoteright}s Research, the Mayo Clinic Foundation, and the Sun Health Foundation. We also thank the Arizona Alzheimer{\textquoteright}s Consortium, National Institute on Aging (AG002132 Core C), the CurePSP Foundation, the Alzheimer{\textquoteright}s Association, the Henry M. Jackson Foundation (HU0001-15-2-0020), Daiichi Sankyo Co., Ltd., the National Institute of Mental Health (R01MH106674), and the National Institute of Biomedical Imaging and Bioengineering (R01EB021711) for funding, the Banner Brain and Body Donation Program for making the data available, and the many individuals who contributed their brains to make this study possible. Publisher Copyright: {\textcopyright} 2017 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association.",
year = "2017",
month = oct,
doi = "10.1002/acn3.447",
language = "English (US)",
volume = "4",
pages = "714--721",
journal = "Annals of Clinical and Translational Neurology",
issn = "2328-9503",
publisher = "John Wiley and Sons Inc.",
number = "10",
}